drugset / Trial / NCT01873950

Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects

NCT01873950

RandomizedCrossoverDouble-blindTreatment

Summary

This study seeks to compare 4 known QT prolonging drugs versus placebo to determine their effects on electrophysiological and other clinical parameters. The underlying purpose is to determine if depolarization and repolarization effects caused by drugs with differing ionic channel mechanisms can be distinguished from one another, and to gauge the sensitivity and specificity of novel signal analyses for detection of depolarization and repolarization changes. Secondarily, to evaluate the exposure response relationship and drug induced effects on the heart rate biomarker relationship.

Timeline

Start
2013-05
Primary completion
2013-07
Completion
2014-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dofetilide Small molecule 500 ug Oral
Subject Quinidine Small molecule 400 mg Oral
Subject Ranolazine Small molecule 1500 mg Oral
Subject Verapamil Other / unclassified 120 mg Oral

Indications

No indication recorded.